loading

Aldeyra Therapeutics Inc (ALDX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
기간 3개월 3개월 3개월 3개월 3개월
Research and Development
14.57%
8.5052
7.4233 12.44 14.97 6.1835
Operating Income/Loss
2.48%
-10.17
-10.43 -16.14 -18.01 -9.3939
Nonoperating Income/Loss
19.39%
0.4014
0.498 1.0246 1.1602 1.3117
Income/Loss From Continuing Operations Before Tax
1.63%
-9.7673
-9.9295 -15.11 -16.85 -8.0821
Income/Loss From Continuing Operations After Tax
1.63%
-9.7673
-9.9295 -15.11 -16.85 -8.0821
Net Income/Loss
1.63%
-9.7673
-9.9295 -15.11 -16.85 -8.0821
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.26%
60.05
59.89 59.53 59.41 59.41
Diluted Average Shares
0.26%
60.05
59.89 59.53 59.41 59.41
Basic Earnings Per Share
5.88%
-0.16
-0.17 -0.25 -0.28 -0.14
Diluted Earnings Per Share
5.88%
-0.16
-0.17 -0.25 -0.28 -0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
자본화:     |  볼륨(24시간):